Cargando…

Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles

BACKGROUND: In addition to alterations concerning the expression of oncogenes and onco-suppressors, melanoma is characterized by the presence of distinctive gangliosides (sialic acid carrying glycosphingolipids). Gangliosides strongly control cell surface dynamics and signaling; therefore, it could...

Descripción completa

Detalles Bibliográficos
Autores principales: Tringali, Cristina, Silvestri, Ilaria, Testa, Francesca, Baldassari, Paola, Anastasia, Luigi, Mortarini, Roberta, Anichini, Andrea, López-Requena, Alejandro, Tettamanti, Guido, Venerando, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132924/
https://www.ncbi.nlm.nih.gov/pubmed/25085576
http://dx.doi.org/10.1186/1471-2407-14-560
_version_ 1782330686625021952
author Tringali, Cristina
Silvestri, Ilaria
Testa, Francesca
Baldassari, Paola
Anastasia, Luigi
Mortarini, Roberta
Anichini, Andrea
López-Requena, Alejandro
Tettamanti, Guido
Venerando, Bruno
author_facet Tringali, Cristina
Silvestri, Ilaria
Testa, Francesca
Baldassari, Paola
Anastasia, Luigi
Mortarini, Roberta
Anichini, Andrea
López-Requena, Alejandro
Tettamanti, Guido
Venerando, Bruno
author_sort Tringali, Cristina
collection PubMed
description BACKGROUND: In addition to alterations concerning the expression of oncogenes and onco-suppressors, melanoma is characterized by the presence of distinctive gangliosides (sialic acid carrying glycosphingolipids). Gangliosides strongly control cell surface dynamics and signaling; therefore, it could be assumed that these alterations are linked to modifications of cell behavior acquired by the tumor. On these bases, this work investigated the correlations between melanoma cell ganglioside metabolism profiles and the biological features of the tumor and the survival of patients. METHODS: Melanoma cell lines were established from surgical specimens of AJCC stage III and IV melanoma patients. Sphingolipid analysis was carried out on melanoma cell lines and melanocytes through cell metabolic labeling employing [3-(3)H]sphingosine and by FACS. N-glycolyl GM3 was identified employing the 14 F7 antibody. Gene expression was assayed by Real Time PCR. Cell invasiveness was assayed through a Matrigel invasion assay; cell proliferation was determined through the soft agar assay, MTT, and [(3)H] thymidine incorporation. Statistical analysis was performed using XLSTAT software for melanoma hierarchical clustering based on ganglioside profile, the Kaplan-Meier method, the log-rank (Mantel-Cox) test, and the Mantel-Haenszel test for survival analysis. RESULTS: Based on the ganglioside profiles, through a hierarchical clustering, we classified melanoma cells isolated from patients into three clusters: 1) cluster 1, characterized by high content of GM3, mainly in the form of N-glycolyl GM3, and GD3; 2) cluster 2, characterized by the appearance of complex gangliosides and by a low content of GM3; 3) cluster 3, which showed an intermediate phenotype between cluster 1 and cluster 3. Moreover, our data demonstrated that: a) a correlation could be traced between patients’ survival and clusters based on ganglioside profiles, with cluster 1 showing the worst survival; b) the expression of several enzymes (sialidase NEU3, GM2 and GM1 synthases) involved in ganglioside metabolism was associated with patients’ survival; c) melanoma clusters showed different malignant features such as growth in soft agar, invasiveness, expression of anti-apoptotic proteins. CONCLUSIONS: Ganglioside profile and metabolism is strictly interconnected with melanoma aggressiveness. Therefore, the profiling of melanoma gangliosides and enzymes involved in their metabolism could represent a useful prognostic and diagnostic tool. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-560) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4132924
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41329242014-08-15 Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles Tringali, Cristina Silvestri, Ilaria Testa, Francesca Baldassari, Paola Anastasia, Luigi Mortarini, Roberta Anichini, Andrea López-Requena, Alejandro Tettamanti, Guido Venerando, Bruno BMC Cancer Research Article BACKGROUND: In addition to alterations concerning the expression of oncogenes and onco-suppressors, melanoma is characterized by the presence of distinctive gangliosides (sialic acid carrying glycosphingolipids). Gangliosides strongly control cell surface dynamics and signaling; therefore, it could be assumed that these alterations are linked to modifications of cell behavior acquired by the tumor. On these bases, this work investigated the correlations between melanoma cell ganglioside metabolism profiles and the biological features of the tumor and the survival of patients. METHODS: Melanoma cell lines were established from surgical specimens of AJCC stage III and IV melanoma patients. Sphingolipid analysis was carried out on melanoma cell lines and melanocytes through cell metabolic labeling employing [3-(3)H]sphingosine and by FACS. N-glycolyl GM3 was identified employing the 14 F7 antibody. Gene expression was assayed by Real Time PCR. Cell invasiveness was assayed through a Matrigel invasion assay; cell proliferation was determined through the soft agar assay, MTT, and [(3)H] thymidine incorporation. Statistical analysis was performed using XLSTAT software for melanoma hierarchical clustering based on ganglioside profile, the Kaplan-Meier method, the log-rank (Mantel-Cox) test, and the Mantel-Haenszel test for survival analysis. RESULTS: Based on the ganglioside profiles, through a hierarchical clustering, we classified melanoma cells isolated from patients into three clusters: 1) cluster 1, characterized by high content of GM3, mainly in the form of N-glycolyl GM3, and GD3; 2) cluster 2, characterized by the appearance of complex gangliosides and by a low content of GM3; 3) cluster 3, which showed an intermediate phenotype between cluster 1 and cluster 3. Moreover, our data demonstrated that: a) a correlation could be traced between patients’ survival and clusters based on ganglioside profiles, with cluster 1 showing the worst survival; b) the expression of several enzymes (sialidase NEU3, GM2 and GM1 synthases) involved in ganglioside metabolism was associated with patients’ survival; c) melanoma clusters showed different malignant features such as growth in soft agar, invasiveness, expression of anti-apoptotic proteins. CONCLUSIONS: Ganglioside profile and metabolism is strictly interconnected with melanoma aggressiveness. Therefore, the profiling of melanoma gangliosides and enzymes involved in their metabolism could represent a useful prognostic and diagnostic tool. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-560) contains supplementary material, which is available to authorized users. BioMed Central 2014-08-01 /pmc/articles/PMC4132924/ /pubmed/25085576 http://dx.doi.org/10.1186/1471-2407-14-560 Text en © Tringali et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tringali, Cristina
Silvestri, Ilaria
Testa, Francesca
Baldassari, Paola
Anastasia, Luigi
Mortarini, Roberta
Anichini, Andrea
López-Requena, Alejandro
Tettamanti, Guido
Venerando, Bruno
Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
title Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
title_full Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
title_fullStr Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
title_full_unstemmed Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
title_short Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
title_sort molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132924/
https://www.ncbi.nlm.nih.gov/pubmed/25085576
http://dx.doi.org/10.1186/1471-2407-14-560
work_keys_str_mv AT tringalicristina molecularsubtypingofmetastaticmelanomabasedoncellgangliosidemetabolismprofiles
AT silvestriilaria molecularsubtypingofmetastaticmelanomabasedoncellgangliosidemetabolismprofiles
AT testafrancesca molecularsubtypingofmetastaticmelanomabasedoncellgangliosidemetabolismprofiles
AT baldassaripaola molecularsubtypingofmetastaticmelanomabasedoncellgangliosidemetabolismprofiles
AT anastasialuigi molecularsubtypingofmetastaticmelanomabasedoncellgangliosidemetabolismprofiles
AT mortariniroberta molecularsubtypingofmetastaticmelanomabasedoncellgangliosidemetabolismprofiles
AT anichiniandrea molecularsubtypingofmetastaticmelanomabasedoncellgangliosidemetabolismprofiles
AT lopezrequenaalejandro molecularsubtypingofmetastaticmelanomabasedoncellgangliosidemetabolismprofiles
AT tettamantiguido molecularsubtypingofmetastaticmelanomabasedoncellgangliosidemetabolismprofiles
AT venerandobruno molecularsubtypingofmetastaticmelanomabasedoncellgangliosidemetabolismprofiles